STOCK TITAN

INOVIO to Present at the 2023 Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PLYMOUTH MEETING, Pa., May 25, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO, and Dr. Michael Sumner, CMO, will present at the 2023 Jefferies Healthcare Conference.

2023 Jefferies Healthcare Conference
Date: Friday, June 9, 2023
Time: 8:00 AM ET
Format: Fireside Chat

During the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.

A webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.

Contacts

Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

Cision View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-2023-jefferies-healthcare-conference-301834353.html

SOURCE INOVIO Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

INO Rankings

INO Latest News

INO Stock Data

66.60M
25.88M
0.85%
33.51%
13.5%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO